Document Detail


Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction.
MedLine Citation:
PMID:  20520214     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes critical pathway toolkit has been updated based on the 2009 focused updates of the American College of Cardiology/American Heart Association guidelines for the management of patients with ST-segment elevation myocardial infarction (STEMI) and American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions guidelines on percutaneous coronary intervention (PCI). This review highlights the major changes cited in the focused updates, which have been incorporated into the STRIVE standing orders for STEMI and unstable angina/non-ST-segment elevation myocardial infarction (UA/NSTEMI). The updated STEMI and UA/NSTEMI standing orders and other tools are available to clinicians online on the STRIVE Web site.
Authors:
Christopher P Cannon
Related Documents :
18278214 - Determinants of final infarct size and incidence of aborted infarction in patients trea...
10499704 - Electrocardiographic manifestations: acute myopericarditis.
2644054 - Heart rate adjustment of st segment depression for improved detection of coronary arter...
7596024 - New markers of remote ischemia in patients with evolving inferior myocardial infarction.
16226744 - Effects of kr-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarctio...
12643384 - Late outcome after arterial switch operation for complete transposition of great arteri...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical pathways in cardiology     Volume:  9     ISSN:  1535-2811     ISO Abbreviation:  Crit Pathw Cardiol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-03     Completed Date:  2010-09-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101165286     Medline TA:  Crit Pathw Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  55-81     Citation Subset:  IM    
Affiliation:
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. cpcannon@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / prevention & control,  therapy*
Angina, Unstable / therapy*
Angioplasty, Transluminal, Percutaneous Coronary
Anticoagulants / administration & dosage
Critical Pathways*
Heparin / administration & dosage
Humans
Myocardial Infarction / prevention & control,  therapy*
Myocardial Reperfusion / methods
Platelet Aggregation Inhibitors / administration & dosage
Practice Guidelines as Topic*
Risk Assessment
Thrombolytic Therapy / contraindications,  standards*
Ticlopidine / administration & dosage,  analogs & derivatives
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Platelet Aggregation Inhibitors; 55142-85-3/Ticlopidine; 9005-49-6/Heparin; 90055-48-4/clopidogrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathway for the Management of Survivors of Out-of-Hospital Cardiac Arrest.
Next Document:  Depression as Modifiable Coronary Risk Factor in the Emergency Department Chest Pain Observation Uni...